AC
TMCI icon

Aristides Capital’s Treace Medical Concepts TMCI Stock Holding History

Aristides Capital’s Portfolio TMCI Stock Details TMCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-70,500
Closed -$173K – 278
2025
Q4 		$173K Buy
+70,500
New +$306K 0.03% 218
2024
Q1 		– Sell
-26,186
Closed -$334K – 357
2023
Q4 		$334K Buy
+26,186
New +$265K 0.12% 114

Other funds holding TMCI

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CBU
CIBC Bancorp USA Chicago, Illinois $74.4B AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Aristides Capital's TMCI Position: Q1 2026 in Review

Aristides Capital sold out of Treace Medical Concepts (TMCI) in Q1 2026, closing a stake of 70,500 shares — an estimated $173K sold.

Aristides Capital first reported a position in TMCI in Q4 2023 and held it in 2 quarters. The position peaked at $334K in Q4 2023. 118 funds tracked by Wall St. Rank hold TMCI as of Q1 2026.

  • Aristides Capital reported no remaining Treace Medical Concepts position as of Q1 2026 after selling out during the quarter.
  • Aristides Capital sold 70,500 Treace Medical Concepts shares in Q1 2026, an estimated $173K.
  • Aristides Capital first reported a position in Treace Medical Concepts in Q4 2023 and held it in 2 quarters.
  • Aristides Capital's Treace Medical Concepts position peaked at $334K in Q4 2023.
  • 118 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q1 2026.

Based on Aristides Capital's 13F filing for Q1 2026, filed 14 May 2026.